                         SEQUENCE LISTING

<110>  INSERM
 
<120>  METHODS FOR THE TREATMENT AND THE DIAGNOSIS OF CANCER

<130>  BIO10222

<160>  3     

<170>  PatentIn version 3.3

<210>  1
<211>  357
<212>  PRT
<213>  Artificial

<220>
<223>  Derived from Env Gibbon Ape Leukaemia Virus

<400>  1

Met Val Leu Leu Pro Gly Ser Met Leu Leu Thr Ser Asn Leu His His 
1               5                   10                  15      


Leu Arg His Gln Met Ser Pro Gly Ser Trp Lys Arg Leu Ile Ile Leu 
            20                  25                  30          


Leu Ser Cys Val Phe Gly Gly Gly Gly Thr Ser Leu Gln Asn Lys Asn 
        35                  40                  45              


Pro His Gln Pro Met Thr Leu Thr Trp Gln Val Leu Ser Gln Thr Gly 
    50                  55                  60                  


Asp Val Val Trp Asp Thr Lys Ala Val Gln Pro Pro Trp Thr Trp Trp 
65                  70                  75                  80  


Pro Thr Leu Lys Pro Asp Val Cys Ala Leu Ala Ala Ser Leu Glu Ser 
                85                  90                  95      


Trp Asp Ile Pro Gly Thr Asp Val Ser Ser Ser Lys Arg Val Arg Pro 
            100                 105                 110         


Pro Asp Ser Asp Tyr Thr Ala Ala Tyr Lys Gln Ile Thr Trp Gly Ala 
        115                 120                 125             


Ile Gly Cys Ser Tyr Pro Arg Ala Arg Thr Arg Met Ala Ser Ser Thr 
    130                 135                 140                 


Phe Tyr Val Cys Pro Arg Asp Gly Arg Thr Leu Ser Glu Ala Arg Arg 
145                 150                 155                 160 


Cys Gly Gly Leu Glu Ser Leu Tyr Cys Lys Glu Trp Asp Cys Glu Thr 
                165                 170                 175     


Thr Gly Thr Gly Tyr Trp Leu Ser Lys Ser Ser Lys Asp Leu Ile Thr 
            180                 185                 190         


Val Lys Trp Asp Gln Asn Ser Glu Trp Thr Gln Lys Phe Gln Gln Cys 
        195                 200                 205             


His Gln Thr Gly Trp Cys Asn Pro Leu Lys Ile Asp Phe Thr Asp Lys 
    210                 215                 220                 


Gly Lys Leu Ser Lys Asp Trp Ile Thr Gly Lys Thr Trp Gly Leu Arg 
225                 230                 235                 240 


Phe Tyr Val Ser Gly His Pro Gly Val Gln Phe Thr Ile Arg Leu Lys 
                245                 250                 255     


Ile Thr Asn Met Pro Ala Val Ala Val Gly Pro Asp Leu Val Leu Val 
            260                 265                 270         


Glu Gln Gly Pro Pro Arg Thr Ser Leu Ala Leu Pro Pro Pro Leu Pro 
        275                 280                 285             


Pro Arg Glu Ala Pro Pro Pro Ser Leu Pro Asp Ser Asn Ser Thr Ala 
    290                 295                 300                 


Leu Ala Thr Ser Ala Gln Thr Pro Thr Val Arg Lys Thr Ile Val Thr 
305                 310                 315                 320 


Leu Asn Thr Pro Pro Pro Thr Thr Gly Asp Arg Leu Phe Asp Leu Val 
                325                 330                 335     


Gln Gly Ala Phe Leu Thr Leu Asn Ala Thr Asn Pro Gly Ala Thr Glu 
            340                 345                 350         


Ser Cys Trp Leu Cys 
        355         


<210>  2
<211>  21
<212>  RNA
<213>  Artificial

<220>
<223>  PiT1 siRNA-A

<400>  2
uaucaguuca gaccacuugu u                                               21


<210>  3
<211>  21
<212>  RNA
<213>  Artificial

<220>
<223>  PiT1 siRNA-B

<400>  3
uaucuaugcu gguuuccucu u                                               21


